CEMIP promotes gefitinib resistance in lung cancer with EGFR-mutation possibly through forming a stable complex CEMIP/c-MYC

Current Opinion in Physiology · Elsevier

Аннотация

Publication date: 2026 Source: BBA Advances, Volume 9 Author(s): Li Li, Jiaxiu Xie, Jinxing Liang, Hua Su, Xiaoju Shen, Xiaoxiang Mo, Xinli Lin, Weidan Tan, Kun Wu, Fucui Zhu, Li Wang, Ying Liu

Читать у издателя →

Похожие статьи